Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease

Author:

Fonarow Gregg C.1,Keech Anthony C.2,Pedersen Terje R.3,Giugliano Robert P.4,Sever Peter S.5,Lindgren Peter6,van Hout Ben7,Villa Guillermo8,Qian Yi9,Somaratne Ransi9,Sabatine Marc S.10

Affiliation:

1. Division of Cardiology, Ronald Reagan University of California, Los Angeles Medical Center2Associate Editor, JAMA Cardiology

2. National Health and Medical Research Council Clinical Trials Centre, Sydney Medical School, the University of Sydney, Sydney, Australia

3. Center for Preventive Medicine, Oslo University Hospital, Ullevål and Medical Faculty, University of Oslo, Oslo, Norway

4. TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts

5. International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, United Kingdom

6. The Swedish Institute for Health Economics, Lund and Department of Learning, Informatics, Management and Ethics, Karolinska Institute, Stockholm, Sweden

7. ScHARR School for Health and Related Research, University of Sheffield, Sheffield, England

8. Economic Modeling CoE, Amgen (Europe) GmbH, Zug, Switzerland

9. Amgen Inc, Thousand Oaks, California

10. TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts11Deputy Editor, JAMA Cardiology

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3